Research has shown that overexpression of STC1 promoted NF‐κB phospho‐P65 (Ser536), thereby inducing apoptosis in cervical cancer cells, revealing STC1 as a potential therapeutic target for cervical cancer [18]. This evidence concerns the gene STC1 and cervical carcinoma.